Display options
Share it on

Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):641. doi: 10.9758/cpn.2020.18.4.641.

Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Changsu Han, Sheng-Min Wang, Won-Myong Bahk, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand, Laura Mandelli, Chi-Un Pae, Alessandro Serretti

Affiliations

  1. Department of Psychiatry, Korea University College of Medicine, Seoul, Korea.
  2. Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  3. International Health Care Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  4. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.
  5. Global Medical Education, New York, NY, USA.
  6. Department of Biomedical and Neuromotor Sciences, Psychiatric Section, University of Bologna, Bologna, Italy.
  7. Department of Cell Death Disease Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.

PMID: 33124599 PMCID: PMC7609217 DOI: 10.9758/cpn.2020.18.4.641

[No abstract available.]

Publication Types